|
Month
|
Topics
|
|
No. 302 December 2019
|
- MHRA Drug Safety Update (Nov/Dec 19)
- NICE Guidance
- NG 143 (Nov 19): Fever in under 5s: assessment and initial management
- NG 144 (Nov 19): Cannabis-based medicinal products
- NG 145 (Nov 19): Thyroid disease: assessment and management
- TA 610 (Nov 19): Pentosan polysulfate sodium for treating bladder pain syndrome
- TA 614 (Dec 19): Cannabidiol with clobazam for treating seizures associated with Dravet syndrome
- TA 615 (Dec 19): Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome
- NG (Dec 19): Menopause: diagnosis and management guideline
- NG 148 (Dec 19): Acute kidney injury: prevention, detection and management guideline
- Shared decision making
- Cognitive psychology - Generalism and satisficers
- Pharma promotion
- Prescribing principles
|
|
No. 301 October 2019
|
- MHRA Drug Safety Update (Sep/Oct 19)
- NICE Guidance
- NG 87 (Sep 19): Attention deficit hyperactivity disorder
- NG 138 (Sep 19): Pneumonia (community-acquired)
- TA 607 (Oct 19): Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
- CG 184 (Oct 19): Gastro-oesophageal reflux disease and dyspepsia in adults
- Bisphosphonates for treating osteoporosis - Patient decision aid
- UTI diagnosis
- Antidepressants for major depressive disorder
- Patient safety
|
|
No. 300 August 2019
|
- MHRA Drug Safety Update (Aug 19)
- CAPC Technical Working Group
- Latanoprost and timolol preservative free eye drops (Fixapost)
- Dorzolamide and timolol eye drops (Cosopt iMulti)
- NICE Guidance
- CG 30 (Jul 19): Long-acting reversible contraception
- NG 136 (Aug 19): Hypertension in adults: diagnosis and management
- TA 597 (Aug 19): Dapagliflozin with insulin for treating type 1 diabetes
- Consider shorter courses of antibiotics
- How to communicate evidence to patients
- Metformin and sulphonylurea
- A blog on the future of shared decision making
- Shared care guidelines
|
|
No. 299 July 2019
|
- MHRA Drug Safety Update (June/July 2019)
- Unlicensed oral liquids in paediatrics
- NICE Guidance
- TA 583 (Jun 19): Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes
- NG 133 (Jun 19): Hypertension in pregnancy
- NG 134 (Jun 19): Depression in children and young people
- Patient engagement
- What is a biosimilar medicine
- Cognitive biases
- Patient safety
|
No. 298 May 2019
|
- MHRA Drug Safety Update (May 2019)
- CAPC Technical Working Group
- Dymista nasal spray
- NICE Guidance
- NG 127 (May 19): Suspected neurological conditions: recognition and referral
- NG 129 (May 19): Crohn’s disease: management
- NG 130 (May 19): Ulcerative colitis: management
- NG 131 (May 19): Prostate cancer: diagnosis and management
- Quality Improvement Guide
- Cognition
- Reforming disease definitions
- Top tips: Dependence forming medications
- Antidepressants
- Community pharmacy guide for GPs & practice staff
|
|
No. 297 April 2019
|
- MHRA Drug Safety Update (Apr 2019)
- NICE Guidance
- NICE TA 572 (Mar 19): Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes
- NG80 - Asthma: diagnosis, monitoring and chronic asthma management - Patient decision aid
- Clinical epidemiology resources
- Omega 3 fatty acid
- Valproate PPP
- The case for being a medical conservative
- If you don't read the book, then please read the blog ....
- Reforming disease definitions
- Top 20 most valuable pills?
|
|
No. 296 March 2019
|
- MHRA Drug Safety Update (Feb / Mar 2019)
- CAPC Technical Working Group
- Hydrocortisone granules in capsules (Alkindi)
- Semaglutide (Ozempic)
- Overdiagnosis blog
- Multimorbidity
- The medical reformation
- NICE Guidance
- CG 103 (Mar 19): Delirium: prevention, diagnosis and management
- NG 120 (Feb 19): Cough (acute): antimicrobial prescribing
- Standardised strengths of inlicensed liquid medicines
|
|
No. 295 January 2019
|
- MHRA Drug Safety Update (Dec 2018)
- NICE Guidance - NICE NG 115 (Dec 18): Chronic obstructive pulmonary disease in over 16s: diagnosis and management
- NICE Guidance - NICE NG 114 (Dec 18): Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing
- Journey of a NICE Guideline - Ever wondered how they are produced?
- Inhaler technique
- Rethinking medicine
- Specialist Pharmacy Service - A great resource!
|
